Cleveland BioLabs
CBLI
#9802
Rank
C$67.92 M
Marketcap
C$4.39
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -C$3.52 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are C$0.63 Million. In 2020 the company made an earning of -C$3.56 Million a decrease over its 2019 earnings that were of -C$3.27 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$3.52 Million-1.08%
2020-C$3.56 Million8.8%
2019-C$3.27 Million-50.81%
2018-C$6.65 Million-14.3%
2017-C$7.76 Million-11.88%
2016-C$8.8 Million-50.9%
2015-C$17.93 Million-10.24%
2014-C$19.97 Million-37.5%
2013-C$31.95 Million-23.2%
2012-C$41.6 Million19.68%
2011-C$34.76 Million133.81%
2010-C$14.87 Million68.22%
2009-C$8.84 Million-55.51%
2008-C$19.86 Million-45.62%
2007-C$36.52 Million255.63%
2006-C$10.27 Million198.18%
2005-C$3.45 Million-1.25%
2004-C$3.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$25.14 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-C$0.23 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.41 B-299,603.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.72 B-596,599.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
C$11.12 B-291,937.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.59 B-330,710.78%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
C$12.90 B-338,799.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-C$17.13 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.15 B-817,651.66%๐Ÿ‡บ๐Ÿ‡ธ USA